aromasil has been researched along with Lung Diseases, Interstitial in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bruna-Muraille, C; Dejust, S; Eymard, JC; Morland, D; Papathanassiou, D; Savoye, AM; Yazbek, G | 1 |
| de Boer, M; de Jong, PC; Gerritsen, WR; Grutters, JC; Jonker, MA; Meek, B; Tol, J; van Erp, NP; van Herpen, CML; van Moorsel, C; Willemsen, AECAB | 1 |
| Goto, Y; Kimura, M; Sakiyama, K; Yoshida, T | 1 |
3 other study(ies) available for aromasil and Lung Diseases, Interstitial
| Article | Year |
|---|---|
Everolimus-induced pulmonary toxicity: Findings on 18F-FDG PET/CT imaging.
Topics: Adult; Aged; Aged, 80 and over; Androstadienes; Breast Neoplasms; Everolimus; Female; Fluorodeoxyglucose F18; Glycolysis; Humans; Lung Diseases, Interstitial; Middle Aged; Positron Emission Tomography Computed Tomography; TOR Serine-Threonine Kinases; Tumor Burden | 2018 |
Prospective Study of Drug-induced Interstitial Lung Disease in Advanced Breast Cancer Patients Receiving Everolimus Plus Exemestane.
Topics: Adult; Aged; Androstadienes; Antineoplastic Agents; Breast Neoplasms; Everolimus; Female; Humans; Lung Diseases, Interstitial; Male; Middle Aged; Prospective Studies; Respiratory Function Tests | 2019 |
[An Elderly Patient with Metastatic Breast Cancer Who Developed Severe Adverse Events such as Stomatitis and Interstitial Pneumonia after Everolimus plus Exemestane Treatment].
Topics: Aged, 80 and over; Androstadienes; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Everolimus; Female; Humans; Lung Diseases, Interstitial; Neoplasm Metastasis; Stomatitis; Thoracic Wall | 2016 |